Resveratrol inhibits the NLRP3 inflammasome pathway and enhances the resistance of chickens to Pasteurella multocida
- 8 July 2026
- journal article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 218, 108687
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Henan Province (252300423634)
This publication has 37 references indexed in Scilit:
- Construction and evaluation of a Salmonella Paratyphi A vaccine candidate based on a poxA gene mutationGene, 2024
- Resveratrol alleviated neuroinflammation induced by pseudorabies virus infection through regulating microglial M1/M2 polarizationBiomedicine & Pharmacotherapy, 2023
- In vitro assessment of Thimerosal cytotoxicity and antimicrobial activityJournal of Trace Elements in Medicine and Biology, 2023
- Resveratrol (RV): A pharmacological review and call for further researchBiomedicine & Pharmacotherapy, 2021
- EntE, EntS and TolC synergistically contributed to the pathogenesis of APEC strain E058Microbial Pathogenesis, 2020
- Antibacterial and antifungal properties of resveratrolInternational Journal of Antimicrobial Agents, 2019
- Inhibition of alpha-hemolysin expression by resveratrol attenuates Staphylococcus aureus virulenceMicrobial Pathogenesis, 2019
- Animals as sources of food-borne pathogens: A reviewAnimal Nutrition, 2018
- Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagyJournal of Cellular Physiology, 2014
- Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activationMetabolism, 2014